KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to $160.2 million.

  • Novavax's Shares Outstanding (Weighted Average) rose 1.45% to $162.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.4 million, marking a year-over-year increase of 1.45%. This contributed to the annual value of $160.2 million for FY2024, which is 34.85% up from last year.
  • As of FY2024, Novavax's Shares Outstanding (Weighted Average) stood at $160.2 million, which was up 34.85% from $118.8 million recorded in FY2023.
  • In the past 5 years, Novavax's Shares Outstanding (Weighted Average) ranged from a high of $160.2 million in FY2024 and a low of $63.7 million during FY2020.
  • For the 3-year period, Novavax's Shares Outstanding (Weighted Average) averaged around $119.2 million, with its median value being $118.8 million (2023).
  • Data for Novavax's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 139.53% (in 2020) over the last 5 years.
  • Over the past 5 years, Novavax's Shares Outstanding (Weighted Average) (Yearly) stood at $63.7 million in 2020, then rose by 18.77% to $75.6 million in 2021, then increased by 3.83% to $78.5 million in 2022, then skyrocketed by 51.32% to $118.8 million in 2023, then soared by 34.85% to $160.2 million in 2024.